Finance

Beta
Lists
KRRO:NASDAQ
Korro Bio Inc
$12.99
+17.56%
(+1.94) 1D
$13.10
+0.85% (+0.11)
After hours
Closed: Jun 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRRO...
Open
$11.38
High
$13.29
Low
$11.23
Mkt. cap
187.35M
Avg. vol.
147.05K
Volume
736.22K
52-wk high
$55.89
52-wk low
$5.20
EPS
-$11.67
Beta
3.01
Shares outstanding
14.42M
No. of employees
49
Open
$11.38
High
$13.29
Low
$11.23
Mkt. cap
187.35M
Avg. vol.
147.05K
Volume
736.22K
52-wk high
$55.89
52-wk low
$5.20
EPS
-$11.67
Beta
3.01
Shares outstanding
14.42M
No. of employees
49
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to KRRO in the past 3 months
Strong Buy
Buy
7
Hold
1
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for KRRO in the last 3 months.
Highest
Current $12.99
$30.00 (+130.95%)
Average
$19.00 (+46.27%)
Lowest
$8.00 (-38.41%)
News stories
From sources across the web
About Korro Bio Inc
CEO-
Employees49
Founded2014
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.46M
1.09M
1.29M
-
Cost of goods sold
18.36M
11.26M
8.60M
11.53M
Cost of revenue
18.36M
11.26M
8.60M
11.53M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.30M
9.06M
8.58M
8.91M
Operating expense
10.30M
9.06M
8.58M
8.91M
Total operating expenses
28.66M
20.33M
17.18M
20.44M
Operating income
-27.20M
-19.24M
-15.88M
-20.44M
Other non operating income
1.43M
1.18M
990.00K
-
EBT including unusual items
-25.77M
-18.06M
-49.41M
-19.53M
EBT excluding unusual items
-25.77M
-18.06M
-14.89M
-19.53M
Income tax expense
1.00K
-
636.00K
95.00K
Effective tax rate
-
-
-1.29%
-0.49%
Other operating expenses
-
-
-
-
Net income
-25.77M
-18.06M
-50.04M
-19.62M
Net profit margin
-1,765.07%
-1,656.97%
-3,873.22%
-
Earnings per share
-2.74
-1.92
-1.65
-1.69
Interest and investment income
-
-
-
906.00K
Interest expense
-
-
-
-
Net interest expenses
-
-
-
906.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-25.98M
-18.06M
-15.23M
-20.06M
Gain or loss from assets sale
81.00K
-
-18.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more